Concepedia

Publication | Open Access

Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial

DOIFull Paper Access

172

Citations

24

References

2019

Year

You‐Lin Qiao, Ting Wu, Rongcheng Li, Yuemei Hu, Lihui Wei, Changgui Li, Wen Chen, Shoujie Huang, Fanghui Zhao, Mingqiang Li,
JNCI Journal of the National Cancer Institute

Abstract

The E coli-produced HPV-16/18 vaccine is well tolerated and highly efficacious against HPV-16/18-associated high-grade genital lesions and persistent infection in women.

References

YearCitations

Page 1